Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Intervalo de año de publicación
1.
J Vet Intern Med ; 32(1): 428-432, 2018 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-29194766

RESUMEN

Myoclonic epilepsy in Rhodesian Ridgeback (RR) dogs is characterized by myoclonic seizures occurring mainly during relaxation periods, a juvenile age of onset and generalized tonic-clonic seizures in one-third of patients. An 8-month-old female intact RR was presented for myoclonic seizures and staring episodes that both started at 10 weeks of age. Testing for the DIRAS1 variant indicated a homozygous mutant genotype. Unsedated wireless video-electroencephalography (EEG) identified frequent, bilaterally synchronous, generalized 4 Hz spike-and-wave complexes (SWC) during the staring episodes in addition to the characteristic myoclonic seizures with generalized 4-5 Hz SWC or 4-5 Hz slowing. Photic stimulation did not evoke a photoparoxysmal response. Repeat video-EEG 2 months after initiation of levetiracetam treatment disclosed a >95% decrease in frequency of myoclonic seizures, and absence seizures were no longer evident. Absence seizures represent another seizure type in juvenile myoclonic epilepsy (JME) in RR dogs, which reinforces its parallels to JME in humans.


Asunto(s)
Enfermedades de los Perros/diagnóstico , Epilepsias Mioclónicas/veterinaria , Convulsiones/veterinaria , Animales , Anticonvulsivantes/uso terapéutico , Enfermedades de los Perros/tratamiento farmacológico , Enfermedades de los Perros/genética , Perros , Electroencefalografía/veterinaria , Femenino , GTP Fosfohidrolasas/genética , Levetiracetam , Mutación , Estimulación Luminosa , Piracetam/análogos & derivados , Piracetam/uso terapéutico , Proteínas Supresoras de Tumor/genética
2.
Eur J Paediatr Neurol ; 20(1): 45-52, 2016 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-26586340

RESUMEN

OBJECTIVES: The incidence of tick-borne encephalitis (TBE) is increasing in many countries. Magnetic resonance imaging (MRI) in the course of TBE is not regularly performed in children. The aim of our study was evaluating MRI-findings of children and adolescents with TBE. PATIENTS AND METHODS: Retrospective evaluation of the charts and MRIs of patients who had been treated for TBE in the four participating hospitals in the last twenty years. RESULTS: 11 patients (5 male; age at TBE 3 weeks-15 9/12 years; mean 104.9 months) were included. MRI (within the first week after admission) revealed symmetric or asymmetric T2-hyperintensities in both thalami in 7/11 patients with additional bilateral lesions in putamen and/or caudate nucleus in 3 patients, and additional cortical lesions in 2 patients. Our youngest patient presented with T2-hyperintensities affecting the whole left cerebral hemisphere including white and grey matter and both cerebellar hemispheres. One patient had a minimal reversible T2-hyperintensity in the splenium of the corpus callosum (RHSCC). 3/11 patients had a normal MRI. 4/11 patients showed complete neurological recovery (2/4 with a normal MRI, RHSCC patient). 6/11 children survived with significant sequelae: hemiparesis (n = 4); cognitive deficits (n = 4); pharmacoresistant epilepsy (n = 2). One patient died of a malignant brain edema. DISCUSSION: A spectrum of MRI findings can be found in children with TBE, often showing involvement of the subcortical deep grey matter structures. In children presenting with a meningoencephalitis and bilateral thalamic involvement TBE should be included in the differential diagnosis.


Asunto(s)
Encefalitis Transmitida por Garrapatas/diagnóstico , Imagen por Resonancia Magnética/métodos , Adolescente , Edema Encefálico/etiología , Núcleo Caudado/patología , Corteza Cerebral/patología , Niño , Preescolar , Trastornos del Conocimiento/etiología , Cuerpo Calloso/patología , Epilepsia Refractaria/etiología , Encefalitis Transmitida por Garrapatas/complicaciones , Encefalitis Transmitida por Garrapatas/terapia , Femenino , Estudios de Seguimiento , Humanos , Lactante , Recién Nacido , Masculino , Paresia/etiología , Putamen/patología , Estudios Retrospectivos , Tálamo/patología , Resultado del Tratamiento
3.
Arch Dis Child ; 96(2): 186-91, 2011 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-20959359

RESUMEN

OBJECTIVE: Limbic encephalitis is rare in people <18 years of age and rarely given a formal diagnosis. DESIGN: Retrospective study on presentation and outcome of children and adolescents with the clinico-radiological syndrome of limbic encephalitis tested for specific neuronal autoantibodies (Abs) over 3.5 years. SETTING: Assessment, diagnosis, treatment and follow-up at 12 neuropaediatric and neurological departments in Europe, with Abs determined in Bonn, Germany and Oxford, UK. PATIENTS: Ten patients <18 years of age who presented with a disorder mainly affecting the limbic areas of <5 years' duration with MRI evidence of mediotemporal encephalitis (hyperintense T2/FLAIR signal, resolving over time). RESULTS: Median age at disease onset was 14 years (range 3-17). Eight patients had defined Abs: one each with Hu or Ma1/2 Abs, four with high titre glutamic acid decarboxylase (GAD) Abs, two of whom had low voltage-gated potassium channel (VGKC) Abs and two with only low titre VGKC Abs. A tumour was only found in the patient with Hu Abs (a neuroblastoma). After a median follow-up of 15 months with corticosteroid or intravenous immunoglobulin treatment, starting after a median of 4 months, two patients recovered, eight remained impaired and one died. CONCLUSIONS: Limbic encephalitis is a disease that can occur in childhood or adolescence with many of the hallmarks of the adult disorder, suggesting that both result from similar pathogenic processes. Since most of the cases were non-paraneoplastic, as now also recognised in adults, more systematic and aggressive immunotherapies should be evaluated in order to improve outcomes.


Asunto(s)
Encefalitis Límbica/diagnóstico , Adolescente , Autoanticuerpos/sangre , Encéfalo/patología , Niño , Preescolar , Femenino , Estudios de Seguimiento , Glucocorticoides/uso terapéutico , Humanos , Inmunoglobulinas Intravenosas/uso terapéutico , Encefalitis Límbica/tratamiento farmacológico , Encefalitis Límbica/inmunología , Imagen por Resonancia Magnética , Masculino , Neuroblastoma/diagnóstico , Neuroblastoma/tratamiento farmacológico , Neuroblastoma/inmunología , Neuronas/inmunología , Síndromes Paraneoplásicos/diagnóstico , Síndromes Paraneoplásicos/tratamiento farmacológico , Síndromes Paraneoplásicos/inmunología , Pronóstico , Estudios Retrospectivos , Resultado del Tratamiento
4.
J Child Neurol ; 15(6): 406-13, 2000 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-10868785

RESUMEN

Heterotopic ossification, or myositis ossificans, denotes true bone in an abnormal place. The pathogenic mechanism is still unclear. A total of 643 patients (mean age, 9.1 years) admitted for neuropediatric rehabilitation were analyzed retrospectively with respect to the existence of neurogenic heterotopic ossification. The purpose of this study was to obtain information about incidence, etiology, clinical aspect, and consequences for diagnosis and therapy of this condition in childhood and adolescence. Heterotopic ossification was diagnosed in 32 patients (mean age, 14.8 years) with average time of onset of 4 months after traumatic brain injury, near drowning, strangulation, cerebral hemorrhage, hydrocephalus, or spinal cord injury. The sex ratio was not significant. In contrast to what has been found in adult studies, serum alkaline phosphatase was not elevated during heterotopic ossification formation. A persistent vegetative state for longer than 30 days proved to be a significant risk factor for heterotopic ossification. The incidence of neurogenic heterotopic ossification in children seems to be lower than in adults. A genetic predisposition to heterotopic ossification is suspected but not proven. As a prophylactic regimen against heterotopic ossification we use salicylates for those patients in a coma or persistent vegetative state with warm and painful swelling of a joint and consider continuous intrathecal baclofen infusion and botulinum toxin injection for those patients with severe spasticity. We prefer to wait at least 1 year after trauma before excision of heterotopic ossification.


Asunto(s)
Miositis Osificante/etiología , Miositis Osificante/prevención & control , Adulto , Edad de Inicio , Lesiones Encefálicas/complicaciones , Neoplasias Encefálicas/complicaciones , Infarto Cerebral/complicaciones , Niño , Preescolar , Encefalitis/complicaciones , Femenino , Francia/epidemiología , Alemania/epidemiología , Humanos , Lactante , Masculino , Miositis Osificante/diagnóstico , Miositis Osificante/epidemiología , Miositis Osificante/cirugía , Ahogamiento Inminente/complicaciones , Estado Vegetativo Persistente/complicaciones , Estudios Retrospectivos , Prevención Secundaria , Traumatismos de la Médula Espinal/complicaciones
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA